These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 824198)

  • 1. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.
    Borel JF
    Immunology; 1976 Oct; 31(4):631-41. PubMed ID: 824198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F; Pavelic Z; Mihich E
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
    Purves EC
    Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response.
    Kölsch E
    Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro induction of cell-mediated cytotoxicity].
    Lohmann-Matthes M-L
    Allerg Immunol (Leipz); 1973; 19(2-4):297-302. PubMed ID: 4281631
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of age on cell-mediated immunity in long-lived mice.
    Goodman SA; Makinodan T
    Clin Exp Immunol; 1975 Mar; 19(3):533-42. PubMed ID: 812622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.
    DeLustro F; Argyris BF
    J Immunol; 1976 Dec; 117(6):2073-80. PubMed ID: 136473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of immunity in parental and F1 hybrid mouse strains to a spontaneously arising parental tumor. I. Correlation between in vitro and in vivo anti-tumor reactivity in responsive and unresponsive animals.
    Levy RB; Waksal SD; Shearer GM
    Eur J Immunol; 1977 Mar; 7(3):170-4. PubMed ID: 862656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by lymphoid cellular factors of the immunological cytotoxicity against a syngeneic tumour.
    Lafontaine N; Firket H
    Pathol Eur; 1976; 11(2):147-50. PubMed ID: 958732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice.
    Greenberg AH; Playfair JH
    Clin Exp Immunol; 1974 Jan; 16(1):99-109. PubMed ID: 4143189
    [No Abstract]   [Full Text] [Related]  

  • 20. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G; Lennox ES
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.